Liquidia (LQDA) Interest Expenses (2019 - 2026)
Liquidia's (LQDA) quarterly Interest Expenses came in at $269.4 million in Q1 2026, up 202.17% year-on-year from $89.1 million in Q1 2025, and up 3804.22% quarter-over-quarter from $6.9 million in Q4 2025.
Liquidia (LQDA) Interest Expenses (2019 - 2026) Analysis & Trends
Liquidia's Interest Expenses history runs 8 years deep, the most recent figure standing at $269.4 million for Q1 2026.
- On a quarterly basis, Interest Expenses rose 202.17% year-over-year to $269.4 million in Q1 2026; TTM through Mar 2026 was $269.4 million, a 202.17% increase from a year earlier, with the FY2025 full-year figure at $248.9 million, up 116.44% from the prior year.
- Interest Expenses rose to $269.4 million in Q1 2026 per LQDA's latest filing, from $6.9 million in the prior quarter.
- Across five years, Interest Expenses topped out at $269.4 million in Q1 2026 and bottomed at -$4.0 million in Q4 2023.
- The 5-year median for Interest Expenses is $22.7 million (2023), against an average of $52.2 million.
- Biggest YoY gain for Interest Expenses was 1573.53% in 2023; the steepest drop was 666.05% in 2023.
- Year by year, Interest Expenses stood at $698000.0 in 2022, then tumbled by 666.05% to -$4.0 million in 2023, then jumped by 214.07% to $4.5 million in 2024, then jumped by 53.07% to $6.9 million in 2025, then surged by 3804.22% to $269.4 million in 2026.
- Per Business Quant, the three latest LQDA Interest Expenses figures stand at $269.4 million (Q1 2026), $6.9 million (Q4 2025), and $153.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.77 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 269.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 269.35 Mn |
| Mar 31, 2026 | 269.35 Mn |
| Dec 31, 2025 | 6.90 Mn |
| Dec 31, 2025 | 6.90 Mn |
| Sep 30, 2025 | 153.32 Mn |
| Sep 30, 2025 | 153.32 Mn |
| Jun 30, 2025 | 68.47 Mn |
| Jun 30, 2025 | 68.47 Mn |
| Mar 31, 2025 | 89.14 Mn |
| Mar 31, 2025 | 89.14 Mn |
| Dec 31, 2024 | 4.51 Mn |
| Dec 31, 2024 | 4.51 Mn |
| Sep 30, 2024 | 47.84 Mn |
| Sep 30, 2024 | 47.84 Mn |
| Jun 30, 2024 | 67.98 Mn |
| Jun 30, 2024 | 67.98 Mn |
| Mar 31, 2024 | 95.04 Mn |
| Mar 31, 2024 | 95.04 Mn |
| Dec 31, 2023 | -3.95 Mn |
| Dec 31, 2023 | -3.95 Mn |